Adicet Bio, Inc.ACETNASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
13.97%
↑ 124% above average
Average (39q)
-57.44%
Historical baseline
Range
High:1090.78%
Low:-1838.34%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 13.97% |
| Q2 2025 | -10.64% |
| Q1 2025 | 1.79% |
| Q4 2024 | 5.75% |
| Q3 2024 | -1.93% |
| Q2 2024 | -6.73% |
| Q1 2024 | 5.00% |
| Q4 2023 | 40.89% |
| Q3 2023 | -53.95% |
| Q2 2023 | -4.93% |
| Q1 2023 | -3.37% |
| Q4 2022 | -35.82% |
| Q3 2022 | 2.40% |
| Q2 2022 | -588.05% |
| Q1 2022 | 129.20% |
| Q4 2021 | -12.85% |
| Q3 2021 | -29.10% |
| Q2 2021 | 49.09% |
| Q1 2021 | -137.99% |
| Q4 2020 | 39.39% |
| Q3 2020 | -74.80% |
| Q2 2020 | -88.48% |
| Q1 2020 | 31.80% |
| Q4 2019 | 55.49% |
| Q3 2019 | -457.45% |
| Q2 2019 | 35.83% |
| Q1 2019 | 93.92% |
| Q4 2018 | -708.79% |
| Q3 2018 | 38.14% |
| Q2 2018 | -37.85% |
| Q1 2018 | 84.63% |
| Q4 2017 | -1838.34% |
| Q3 2017 | -113.05% |
| Q2 2017 | 353.78% |
| Q1 2017 | 1090.78% |
| Q4 2016 | -112.86% |
| Q3 2016 | -20.14% |
| Q2 2016 | -47.32% |
| Q1 2016 | 26.05% |
| Q4 2015 | -11.06% |